Pancreatic peptide hormone
Amylin
Amylin, also called IAPP, is a pancreatic peptide hormone. Its historical name comes from studies of amyloid deposits, but the molecule was also identified in normal islet cells; the peptide should not be confused with any deposit containing it.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Ligand, receptor and formulation
Keep entity and method together: transferring a result between formulations requires evidence even when their names overlap.
- Is the experimental entity the hormone, a fragment, an analog or a complete formulation?
- Does the readout measure receptor binding, an intracellular signal or an outcome in another system?
- Are species, expressed receptor, comparator and readout time reported?
Mechanism described in the literature
In cellular models, combining the calcitonin receptor with particular RAMP proteins generated amylin recognition and signaling profiles. An amylin receptor can therefore designate a component complex rather than an isolated protein.
Other names in the literature
- Amylin
- IAPP
- Islet amyloid polypeptide
What the initial isolation revealed
The 1987 study examined amyloid material from islets and an insulinoma and used immunohistochemical tools to locate IAPP. It distinguished molecular identification and tissue distribution. Finding the peptide in deposits and normal cells does not demonstrate that both material forms behave identically.
RAMP changes receptor interpretation
The 1999 publication compared calcitonin receptor combinations with different RAMP proteins in COS-7 cells. In vitro, some combinations produced specific amylin binding and cyclic AMP responses. Differences between combinations showed that the accompanying protein is part of the functional identity.
What a comparison must describe
An affinity table needs to identify the receptor variant, incorporated RAMP and ligand used. Omitting these can make different systems appear to be replicates. Signaling studies of soluble peptide must also be distinguished from aggregation research: they share an originating entity but examine different properties.
Questions and answers
Does IAPP mean the sample contains amyloid?
No. It is a peptide name and does not by itself determine a preparation's aggregation state.
Is expressing the calcitonin receptor enough to define an amylin receptor?
No. In the cited systems, combination with RAMP proteins was decisive for the observed profile.
Sources
- Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. — Proc Natl Acad Sci U S A, 1987
- Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
- Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. — Mol Pharmacol, 1999
- Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.